Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1974 Aug 24;3(5929):508–510. doi: 10.1136/bmj.3.5929.508

Aetiology of hyperthyroidism. II.

R Hoffenberg
PMCID: PMC1611236  PMID: 4369764

Full text

PDF
509

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. D., Kennedy T. H. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J Clin Endocrinol Metab. 1967 Feb;27(2):173–177. doi: 10.1210/jcem-27-2-173. [DOI] [PubMed] [Google Scholar]
  2. Adlkofer F., Schleusener H., Uher L., Ananos A. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies. Acta Endocrinol (Copenh) 1973 Jul;73(3):483–488. doi: 10.1530/acta.0.0730483. [DOI] [PubMed] [Google Scholar]
  3. Alexander W. D., Harden R. M., Shimmins J. Emotion and non-specific infection as possible aetiological factors in Graves' disease. Their relation to thyroid suppressibility. Lancet. 1968 Jul 27;2(7561):196–197. doi: 10.1016/s0140-6736(68)92626-3. [DOI] [PubMed] [Google Scholar]
  4. Amir S. M., Carraway T. F., Jr, Kohn L. D., Winand R. J. The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem. 1973 Jun 10;248(11):4092–4100. [PubMed] [Google Scholar]
  5. Aoki V. S., Wilson W. R., Theilen E. O. Studies of the reputed augmentation of the cardiovascular effects of catecholamines in patients with spontaneous hyperthyroidism. J Pharmacol Exp Ther. 1972 May;181(2):362–368. [PubMed] [Google Scholar]
  6. Beall G. N., Solomon D. H. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes. J Clin Endocrinol Metab. 1968 Apr;28(4):503–510. doi: 10.1210/jcem-28-4-503. [DOI] [PubMed] [Google Scholar]
  7. Beall G., Doniach D., Roitt I., el Kabir D. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions. J Lab Clin Med. 1969 Jun;73(6):988–999. [PubMed] [Google Scholar]
  8. Berumen F. O., Lobsenz I. L., Utiger R. D. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions. J Lab Clin Med. 1967 Oct;70(4):640–649. [PubMed] [Google Scholar]
  9. Bonnyns M., Demeester-Mirkine N., Calay R., Bastenie P. A. Evaluation of the relationship between long-acting thyroid stimulator, clinical and biological thyrotoxicosis and exophthalmos. Acta Endocrinol (Copenh) 1968 Aug;58(4):581–592. doi: 10.1530/acta.0.0580581. [DOI] [PubMed] [Google Scholar]
  10. Brody J. I., Greenberg S. Lymphocyte dysfunction in thyrotoxicosis. J Clin Endocrinol Metab. 1972 Oct;35(4):574–579. doi: 10.1210/jcem-35-4-574. [DOI] [PubMed] [Google Scholar]
  11. Burke G. Thyroid stimulators and thyroid stimulation. Acta Endocrinol (Copenh) 1971 Mar;66(3):558–576. doi: 10.1530/acta.0.0660558. [DOI] [PubMed] [Google Scholar]
  12. Carneiro L., Dorrington K. J., Munro D. S. Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin G. Clin Sci. 1966 Oct;31(2):215–221. [PubMed] [Google Scholar]
  13. Carneiro L., Dorrington K. J., Munro D. S. Relation between long-acting thyroid stimulator and thyroid function in thyrotoxicosis. Lancet. 1966 Oct 22;2(7469):878–880. doi: 10.1016/s0140-6736(66)91978-7. [DOI] [PubMed] [Google Scholar]
  14. Chopra I. J., Beall G. N., Solomon D. H. LATS inhibition by a soluble lipoprotein from human thyroid gland. J Clin Endocrinol Metab. 1971 Jun;32(6):772–778. doi: 10.1210/jcem-32-6-772. [DOI] [PubMed] [Google Scholar]
  15. Chopra I. J., Solomon D. H. Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy, and high serum LATS. Ann Intern Med. 1970 Dec;73(6):985–990. doi: 10.7326/0003-4819-73-6-985. [DOI] [PubMed] [Google Scholar]
  16. Chopra I. J., Solomon D. H., Johnson D. E., Chopra U. Thyroid gland in Graves' disease: victim or culprit? Metabolism. 1970 Oct;19(10):760–772. doi: 10.1016/0026-0495(70)90074-0. [DOI] [PubMed] [Google Scholar]
  17. Chopra I. J., Solomon D. H., Limberg N. P. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS). J Clin Endocrinol Metab. 1970 Oct;31(4):382–390. doi: 10.1210/jcem-31-4-382. [DOI] [PubMed] [Google Scholar]
  18. Dirmikis S., Munro D. S. Studies on the binding activity for the long-acting thyroid stimulator. J Endocrinol. 1973 Sep;58(3):577–590. doi: 10.1677/joe.0.0580577. [DOI] [PubMed] [Google Scholar]
  19. Edmonds M. W., Row V. V., Volpé R. Action of globulin and lymphocytes from peripheral blood of patients with Graves' disease on isolated bovine thyroid cells. J Clin Endocrinol Metab. 1970 Nov;31(5):480–490. doi: 10.1210/jcem-31-5-480. [DOI] [PubMed] [Google Scholar]
  20. Ericson L. E., Håkanson R., Melander A., Owman C., Sundler F. TSH-induced release of 5-hydroxytryptamine and histamine rat thyroid mast cells. Endocrinology. 1972 Mar;90(3):795–801. doi: 10.1210/endo-90-3-795. [DOI] [PubMed] [Google Scholar]
  21. FALCONER I. R., HETZEL B. S. EFFECT OF EMOTIONAL STRESS AND TSH ON THYROID VEIN HORMONE LEVEL IN SHEEP WITH EXTERIORIZED THYROIDS. Endocrinology. 1964 Jul;75:42–48. doi: 10.1210/endo-75-1-42. [DOI] [PubMed] [Google Scholar]
  22. Fayet G., Verrier B., Giraud A., Lissitzky S., Pinchera A., Romaldini J. H., Fenzi G. Effects of long-acting thyroid stimulator on the reorganization into follicles of isolated thyroid cells and on the binding of radioiodinated thyrotropin to reassociated cells. FEBS Lett. 1973 Jun 1;32(2):299–302. doi: 10.1016/0014-5793(73)80858-0. [DOI] [PubMed] [Google Scholar]
  23. Forteza M. E. Precipitating factors in hyperthyroidism. Geriatrics. 1973 Feb;28(2):123–126. [PubMed] [Google Scholar]
  24. HERMANN H. T., QUARTON G. C. PSYCHOLOGICAL CHANGES AND PSYCHOGENESIS IN THYROID HORMONE DISORDERS. J Clin Endocrinol Metab. 1965 Mar;25:327–338. doi: 10.1210/jcem-25-3-327. [DOI] [PubMed] [Google Scholar]
  25. Hetzel B. S. The aetiology and pathogenesis of hyperthyroidism. Postgrad Med J. 1968 May;44(511):363–376. doi: 10.1136/pgmj.44.511.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Krass M. E., LaBella F. S., Vivian S. R. Thyrotrophin release in vitro: the role of metabolism in the secretory response to vasopressin, oxytocin and epinephrine. Endocrinology. 1968 Jun;82(6):1183–1189. doi: 10.1210/endo-82-6-1183. [DOI] [PubMed] [Google Scholar]
  27. Lamki L., Row V. V., Volpé R. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J Clin Endocrinol Metab. 1973 Feb;36(2):358–364. doi: 10.1210/jcem-36-2-358. [DOI] [PubMed] [Google Scholar]
  28. Liddle G. W., Heyssel R. M., McKenzie J. M. Graves' disease without hyperthyroidism. Am J Med. 1965 Nov;39(5):845–848. doi: 10.1016/0002-9343(65)90104-x. [DOI] [PubMed] [Google Scholar]
  29. Lipman L. M., Green D. E., Snyder N. J., Nelson J. C., Solomon D. H. Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease. Am J Med. 1967 Oct;43(4):486–498. doi: 10.1016/0002-9343(67)90175-1. [DOI] [PubMed] [Google Scholar]
  30. Lissitzky S., Fayet G., Giraud A., Verrier B., Torresani J. Thyrotrophin-induced aggregation and reorganization into follicles of isolated porcine-thyroid cells. 1. Mechanism of action of thyrotrophin and metabolic properties. Eur J Biochem. 1971 Dec 22;24(1):88–99. doi: 10.1111/j.1432-1033.1971.tb19658.x. [DOI] [PubMed] [Google Scholar]
  31. Lissitzky S., Fayet G., Verrier B., Hennen G., Jaquet P. Thyroid-stimulating hormone binding to cultured thyroid cells. FEBS Lett. 1973 Jan 1;29(1):20–24. doi: 10.1016/0014-5793(73)80006-7. [DOI] [PubMed] [Google Scholar]
  32. MILGROM F., WITEBSKY E. Autoantibodies and autoimmune diseases. JAMA. 1962 Aug 25;181:706–716. [PubMed] [Google Scholar]
  33. Mashieu P., Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab. 1972 Jun;34(6):1090–1092. doi: 10.1210/jcem-34-6-1090. [DOI] [PubMed] [Google Scholar]
  34. McKenzie J. M. Humoral factors in the pathogenesis of Graves' disease. Physiol Rev. 1968 Jan;48(1):252–310. doi: 10.1152/physrev.1968.48.1.252. [DOI] [PubMed] [Google Scholar]
  35. McKenzie J. M., McCullagh E. P. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease. J Clin Endocrinol Metab. 1968 Aug;28(8):1177–1182. doi: 10.1210/jcem-28-8-1177. [DOI] [PubMed] [Google Scholar]
  36. Miyai K., Fukuchi M., Kumahara Y., Abe H. LATS production by lymphocyte culture in patients with Graves' disease. J Clin Endocrinol Metab. 1967 Jun;27(6):855–860. doi: 10.1210/jcem-27-6-855. [DOI] [PubMed] [Google Scholar]
  37. Mori T., Kriss J. P. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab. 1971 Oct;33(4):688–698. doi: 10.1210/jcem-33-4-688. [DOI] [PubMed] [Google Scholar]
  38. Munro D. S. The long-acting thyroid stimulator. J R Coll Physicians Lond. 1972 Apr;6(3):309–315. [PMC free article] [PubMed] [Google Scholar]
  39. PIMSTONE B. L., HOFFENBERG R., BLACK E. PARALLEL ASSAYS OF THYROTROPHIN, LONG-ACTING THYROID STIMULATOR AND EXOPHTHALMOS-PRODUCING SUBSTANCE IN ENDOCRINE EXOPHTHALMOS AND PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab. 1964 Oct;24:976–982. doi: 10.1210/jcem-24-10-976. [DOI] [PubMed] [Google Scholar]
  40. PINCHERA A., PINCHERA M. G., STANBURY J. B. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE. J Clin Endocrinol Metab. 1965 Feb;25:189–208. doi: 10.1210/jcem-25-2-189. [DOI] [PubMed] [Google Scholar]
  41. Parsons V., Ramsay I. Thyroid and adrenal relationships. Postgrad Med J. 1968 May;44(511):377–384. doi: 10.1136/pgmj.44.511.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. SNYDER N. J., GREEN D. E., SOLOMON D. H. GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE. J Clin Endocrinol Metab. 1964 Nov;24:1129–1135. doi: 10.1210/jcem-24-11-1129. [DOI] [PubMed] [Google Scholar]
  43. Sato S., Noguchi S., Noguchi A. Purification and characterization of long-acting thyroid stimulator inhibiting factor from human thyroid tissues. Biochim Biophys Acta. 1972 Jul 19;273(2):299–307. doi: 10.1016/0304-4165(72)90221-8. [DOI] [PubMed] [Google Scholar]
  44. Shishiba Y., Shimizu T., Yoshimura S., Shizume K. Direct evidence for human thyroidal stimulation by LATS-protector. J Clin Endocrinol Metab. 1973 Mar;36(3):517–521. doi: 10.1210/jcem-36-3-517. [DOI] [PubMed] [Google Scholar]
  45. Smith B. R. The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro. J Endocrinol. 1970 Jan;46(1):45–54. doi: 10.1677/joe.0.0460045. [DOI] [PubMed] [Google Scholar]
  46. WERNER S. C., SPOONER M. A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method. Bull N Y Acad Med. 1955 Feb;31(2):137–145. [PMC free article] [PubMed] [Google Scholar]
  47. Werner S. C., Platman S. R. Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone. Lancet. 1965 Oct 16;2(7416):751–755. doi: 10.1016/s0140-6736(65)90810-x. [DOI] [PubMed] [Google Scholar]
  48. Werner S. C., Wegelius O., Hsu K. C. Immune responses in stroma and basement membranes of the Graves' disease thyroid(IgM; IgE, IgG, and complement). Trans Assoc Am Physicians. 1971;84:139–143. [PubMed] [Google Scholar]
  49. Yamashita K., Field J. B. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes. J Clin Invest. 1972 Mar;51(3):463–472. doi: 10.1172/JCI106834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yamashita K., Field J. B. Preparation of thyroid plasma membranes containing a TSH-responsive adenyl cyclase. Biochem Biophys Res Commun. 1970 Jul 13;40(1):171–178. doi: 10.1016/0006-291x(70)91062-4. [DOI] [PubMed] [Google Scholar]
  51. el-Khatib S. M., Haldar J., Starr J. L. The effect of LATS and TSH on protein and RNA synthesis in isolated thyroid cells. Proc Soc Exp Biol Med. 1973 Jul;143(3):869–878. doi: 10.3181/00379727-143-37432. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES